Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 1996

View Archived Issues

GRF analogs under study at Tulane University

Benzothiophene compounds for women's health disclosed by Lilly

Merck & Co. reveals new agents for BPH

New antiinflammatory agents disclosed by DuPont Merck

Sugen reports antihyperproliferative agents

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

New neuroleptic agents reported by Ferrer

Japanese academic researchers isolate new quassinoid compound

Avitar's collection system marketed for DNA testing

U.S. market introduction for novel antifungal formulation

HemispheRx CFS diagnostic receives European patent approval

Roberts in-licenses another GI drug from Lilly

BMS reports results from cefprozil multicenter clinical study in AOM patients

P&U anticipates filing for urinary incontinence treatment soon

FDA approves new agent for spasticity

FemPatch approved for marketing in U.S.

CytRx subsidiary to merge with Zynaxis

Paracetamol safety established in pregnant mothers and their babies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...